Theracryf Income Statement

Financials in millions GBP. Fiscal year is April - March.

Millions GBP. Fiscal year is Apr - Mar.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '25 Sep 30, 2025	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021
Revenue	-	-	0.4	0.44	-	0.19
Revenue Growth (YoY)	-	-	-10.41%	-	-	-
Gross Profit	-	-	0.4	0.44	-	0.19
Other Operating Expenses	2.25	2.12	3.96	5.55	3.19	3.41
Total Operating Expenses	2.25	2.12	3.96	5.55	3.19	3.41
Operating Income	-2.25	-2.12	-3.57	-5.1	-3.19	-3.21
Interest Income	0.06	0.01	-	0.1	0.02	-
Other Non-Operating Income (Expense)	0.03	0.03	-	-	-	-
Total Non-Operating Income (Expense)	0.09	0.04	-	0.1	0.02	-
Pretax Income	-2.15	-2.09	-3.57	-5.01	-3.17	-3.21
Provision for Income Taxes	-0.14	-0.14	-0.43	-0.96	-0.44	-0.54
Net Income	-2.01	-1.94	-3.14	-4.04	-2.73	-2.67
Net Income to Common	-2.01	-1.94	-3.14	-4.04	-2.73	-2.67
Net Income Growth	-	-	-	-	-	-
Shares Outstanding (Basic)	1,399	538	275	275	275	147
Shares Outstanding (Diluted)	1,421	560	275	275	275	147
Shares Change (YoY)	153.64%	103.83%	-	-	86.97%	13.69%
EPS (Basic)	-0.00	-0.00	-0.01	-0.01	-0.01	-0.02
EPS (Diluted)	-0.00	-0.00	-0.01	-0.01	-0.01	-0.02
EPS Growth	-	-	-	-	-	-
Free Cash Flow	-1.7	-2.37	-3	-4.13	-2.59	-2.93
Free Cash Flow Growth	-	-	-	-	-	-
Free Cash Flow Per Share	-0.00	-0.00	-0.01	-0.02	-0.01	-0.02
Gross Margin	-	-	100.00%	100.00%	-	100.00%
Operating Margin	-	-	-900.51%	-1154.75%	-	-1656.19%
Profit Margin	-	-	-792.17%	-914.71%	-	-1378.35%
FCF Margin	-	-	-756.57%	-933.94%	-	-1510.82%
EBITDA	-2.21	-2.06	-3.55	-5.09	-3.18	-3.2
EBITDA Margin	-	-	-897.48%	-1151.81%	-	-1646.91%
EBIT	-2.25	-2.12	-3.57	-5.1	-3.19	-3.21
EBIT Margin	-	-	-900.51%	-1154.75%	-	-1656.19%
Effective Tax Rate	6.69%	6.91%	12.03%	19.24%	13.85%	16.78%